Financial Data and Key Metrics - Q3 2024 consolidated revenue was $641 million, a 3% YoY decrease [24] - Q3 2024 adjusted EBITDA was $83.3 million, down 6% YoY, with a margin of 13% [24] - Q3 2024 net loss per share was $0.19, compared to $0.35 in Q3 2023 [25] - Q3 2024 free cash flow was $79 million, up 16% YoY [26] - Cash and cash equivalents at the end of Q3 2024 were over $1.2 billion [26] Business Segment Performance Integrated Care - Q3 2024 revenue was $384 million, up 2.5% YoY, exceeding guidance [27] - U.S. Integrated Care membership reached 93.9 million, up 4% YoY and 1.5 million sequentially [28] - Chronic Care program enrollment was 1.18 million, up 5% YoY [29] - International Integrated Care revenue grew in the high-teens on a constant currency basis [29] - Adjusted EBITDA for Integrated Care was $68 million, up 8% YoY, with a margin of 17.7% [32] BetterHelp - Q3 2024 revenue was $257 million, down 10% YoY [33] - Average paying users declined by 2% sequentially and 13% YoY [34] - Adjusted EBITDA for BetterHelp was $15.2 million, down from $26 million in Q3 2023 [36] - Adjusted EBITDA margin for BetterHelp was 5.9%, down 320 basis points YoY [36] Market Performance - U.S. market faces high medical cost trends and customer demand for more value from virtual care [13] - International Integrated Care shows strong momentum with geographic expansion and market penetration [15] - BetterHelp is focusing on stabilizing U.S. results and growing internationally [17] Strategic Direction and Industry Competition - Company is streamlining leadership, rationalizing priorities, and improving execution to address operational challenges [10] - Focus on enhancing value proposition in U.S. Integrated Care through virtual visits and chronic condition management [14] - International Integrated Care is a core priority for growth, with investments planned [15] - BetterHelp is exploring initiatives to allow consumers to access coverage benefits, with discussions underway with health plans [18] - Company is leveraging technology to drive scale, differentiation, and integrated member/provider experiences [20] - Clinical excellence remains a core pillar, with a focus on product roadmap and service delivery [21] Management Commentary on Operating Environment and Future Outlook - Company is navigating a challenging U.S. market with high medical cost trends and customer demand for value [13] - Management is confident in the company's ability to unlock growth potential through strategic investments [23] - For 2025, the company expects revenue growth in line with Q4 2024 projections, with continued margin expansion [47] - BetterHelp is expected to face tough comps in 2025 due to elevated customer acquisition costs [51] - Company is committed to maintaining adjusted EBITDA margins in 2025 in line with 2024 levels [50] Other Important Information - Company recorded a $3.6 million charge related to severance and lease termination costs in Q3 2024 [26] - Q4 2024 guidance for Integrated Care revenue is flat to up 2.5%, with adjusted EBITDA margin between 12.25% and 13.75% [38] - Full-year 2024 adjusted EBITDA margin is expected to be 14.9% to 15.3%, with adjusted EBITDA dollars up approximately 20% YoY [39] - U.S. Integrated Care membership guidance for 2024 is raised to 93.5 to 94.5 million [40] Q&A Session Summary Question: BetterHelp's transition to fee-for-service model - Company is focused on stabilizing the U.S. business and improving profitability [58] - Discussions with health plans and partners are underway to enable consumers to access coverage benefits [59] - Transition is being approached methodically to ensure investments align with returns [60] Question: Competitive landscape in virtual care - Company emphasizes its scale and ability to deliver virtual visits efficiently [61] - Membership growth supports cross-selling opportunities through the land-and-expand strategy [63] Question: 2025 selling season and retention - Bookings are lower YoY, particularly in the health plan space, due to market pressures [67] - Retention rate remains above 90%, but is slightly lower than prior years [66] - Company is focusing on driving enrollment, visit volume, and pricing strategies to grow revenue [72] Question: BetterHelp's payer-sponsored arrangements - BetterHelp remains primarily a direct-to-consumer model, with initiatives to explore coverage benefits [76] - Company is leveraging existing B2B relationships to advance discussions with payers [78] Question: Investments and repositioning for 2025 - Company is evaluating capital allocation to align with strategic priorities and balance investments with returns [81] - Investments are expected to improve revenue growth and operating metrics, such as CCM conversion rates [82] Question: BetterHelp user count stabilization - Stabilization in user count is driven by international ad spend and stable retention/churn metrics [87] - Q4 ad spend will be reduced, but less sharply than in prior years, impacting Q1 2025 user growth [88] Question: 2025 revenue growth and margin outlook - Company expects 2025 revenue growth to be consistent with Q4 2024 projections, with flat to slightly up margins [91] - Investments in 2025 will focus on strengthening the business and adapting to market demands [49] Question: Product improvements and retention - Company is focusing on improving performance management and product integration to drive better outcomes [100] - Investments in capabilities will enhance the value of virtual visits and align with health plan strategies [103] Question: Utilization trends in Integrated Care - Visit revenue growth is strong, driven by membership gains and accretive visit volumes [113] - Company expects continued growth in visit revenue and engagement as new members are onboarded [114] Question: Tech and development spend - Company is rationalizing tech and development spend to align with strategic priorities and create efficiencies [118] - Overall spend is expected to decrease over time, freeing up capacity for future investments [119] Question: G&A expense step-up in Q4 - G&A increase in Q4 is due to one-off investments and is not expected to continue into 2025 [122] - Company will manage expense base relative to revenue growth across both Integrated Care and BetterHelp [122]

For the quarter ended September 2024, Teladoc (TDOC) reported revenue of $640.51 million, down 3% over the same period last year. EPS came in at -$0.19, compared to -$0.35 in the year-ago quarter. The reported revenue represents a surprise of +1.59% over the Zacks Consensus Estimate of $630.5 million. With the consensus EPS estimate being -$0.29, the EPS surprise was +34.48%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...

Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 34.48%. A quarter ago, it was expected that this telehealth services provider would post a loss of $0.36 per share when it actually produced a loss of $0.28, delivering a surprise of 22.22%.Over the last four quarters, the company ...

3Q-24 Quarterly Results Cautionary Note • This presentation contains, and the officers of Teladoc Health, Inc. (the "Company" or "Teladoc Health") may make, "forward-looking" statements that are based on management's beliefs and assumptions and on information currently available to management. These forward-looking statements include, without limitation, information concerning possible or assumed future results of operations, including descriptions of the Company's business plan and strategies. These statem ...

Revenue Performance - Third Quarter 2024 revenue of $640.5 million, down 3% year-over-year[2] - Revenue for Q3 2024 decreased by 3% to $640.5 million compared to $660.2 million in Q3 2023[24] - Nine Months Ended September 30, 2024 revenue decreased 1% to $1,929.1 million from $1,941.9 million in 2023[8] - Revenue for the nine months ended September 30, 2024, was $1.93 billion, slightly down from $1.94 billion in 2023[42] - U.S. revenue decreased 6% to $536.2 million, while International revenue grew 15% to $104.3 million[5] - U.S. Revenue declined by 6% to $536.2 million in Q3 2024, while International Revenue increased by 15% to $104.3 million[24] Segment Performance - Integrated Care segment revenue of $383.7 million, up 2% year-over-year, with adjusted EBITDA margin improved to 17.7%[2] - BetterHelp segment revenue of $256.8 million, down 10% year-over-year, with adjusted EBITDA margin of 5.9%[2] - Teladoc Health Integrated Care Revenue increased by 2% to $383.7 million in Q3 2024[29] - BetterHelp Total Revenue decreased by 10% to $256.8 million in Q3 2024[29] - Adjusted EBITDA for Teladoc Health Integrated Care increased by 8% to $68.0 million in Q3 2024[29] - Adjusted EBITDA Margin for BetterHelp decreased to 5.9% in Q3 2024 from 9.1% in Q3 2023[29] - Teladoc Health Integrated Care segment Adjusted EBITDA increased to $68.0 million in Q3 2024 from $62.8 million in Q3 2023[44] - BetterHelp segment Adjusted EBITDA decreased to $15.2 million in Q3 2024 from $25.9 million in Q3 2023[44] Net Loss and EBITDA - Third Quarter 2024 net loss of $33.3 million, or $0.19 per share[2] - Third Quarter 2024 adjusted EBITDA of $83.3 million, down 6% year-over-year[2] - Net loss for the nine months ended September 30, 2024, was $952.8 million, compared to $191.5 million in the same period in 2023[31] - Net loss for Q3 2024 was $33.3 million, compared to $57.1 million in Q3 2023, showing a 41.7% improvement[44] - Consolidated Adjusted EBITDA for Q3 2024 was $83.3 million, slightly down from $88.8 million in Q3 2023[44] Cash Flow and Capital Expenditures - Net cash provided by operating activities for the nine months ended September 30, 2024, was $207.8 million, down from $219.9 million in 2023[31] - Net cash provided by operating activities for the three months ended September 30, 2024, was $110.2 million, up from $105.6 million in 2023[33] - Free Cash Flow for Q3 2024 was $79.0 million, up from $68.0 million in Q3 2023[45] - Capital expenditures for Q3 2024 were $31.1 million, down from $37.6 million in Q3 2023[45] - Capitalized software development costs for the nine months ended September 30, 2024, were $89.8 million, down from $109.8 million in 2023[31] - Cash and cash equivalents at the end of the period were $1.24 billion, up from $1.03 billion at the end of 2023[31] Goodwill Impairment - Non-cash goodwill impairment charge of $790.0 million recorded in the first nine months of 2024, primarily related to the BetterHelp segment[9] - Goodwill impairment of $790.0 million was recorded in the nine months ended September 30, 2024, compared to none in 2023[31] Membership and Enrollment - U.S. Integrated Care Members expected to be 93.5 - 94.5 million for the full year of 2024[14] - U.S. Integrated Care Members increased by 4% to 93.9 million in Q3 2024[26] - Chronic Care Program Enrollment grew by 5% to 1.179 million in Q3 2024[26] - BetterHelp Paying Users decreased by 13% to 0.398 million in Q3 2024[27] - U.S. Integrated Care Members represent unique individuals with access to integrated care services at the end of the period[46] - Chronic Care Program Enrollment represents total enrollees across chronic care programs at the end of the period[48] - BetterHelp Paying Users represent the average number of global monthly paying users of therapy services[49] Total Visits and Adjusted Gross Profit - Total Visits decreased by 7% to 4.1 million in Q3 2024 compared to 4.4 million in Q3 2023[25] - Adjusted gross profit for the nine months ended September 30, 2024, was $1.37 billion, with an adjusted gross margin of 70.8%, consistent with 2023[42] Assets and Liabilities - Total assets as of September 30, 2024, were $3.53 billion, down from $4.39 billion at the end of 2023[34] - Total liabilities as of September 30, 2024, were $2.02 billion, down from $2.07 billion at the end of 2023[34] Business Segments Overview - The company operates two segments: Teladoc Health Integrated Care and BetterHelp, offering various virtual medical and therapy services[50] Future Expectations - For the fourth quarter of 2024, Integrated Care segment revenue growth expected to be 0% - 2.5% year-over-year, with adjusted EBITDA margin of 12.25% - 13.75%[14]

Wall Street analysts expect Teladoc (TDOC) to post quarterly loss of $0.29 per share in its upcoming report, which indicates a year-over-year increase of 17.1%. Revenues are expected to be $630.5 million, down 4.5% from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. Prior to a company's earnings announcement, it is crucial to co ...

In the latest trading session, Teladoc (TDOC) closed at $8.60, marking a -0.92% move from the previous day. The stock's performance was behind the S&P 500's daily gain of 0.22%. At the same time, the Dow lost 0.33%, and the tech-heavy Nasdaq gained 0.76%.Heading into today, shares of the telehealth services provider had gained 2.48% over the past month, outpacing the Medical sector's loss of 3.79% and the S&P 500's gain of 1.47% in that time.Market participants will be closely following the financial result ...

If you'd like to learn more about how to best position yourself in under valued stocks mispriced by the market to start Q4, consider joining Out Fox The Street . Teladoc Health, Inc. (NYSE: TDOC ) is showing signs of hitting bottom after the company withdrew guidance following a big quarterly miss with the new CEO. The telehealth platform is still looking for the next growth catalyst, which could Mark leads the investing group Out Fox The Street where he shares stock picks and deep research to help readers ...

PURCHASE, NY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release third quarter 2024 results on Wednesday, October 30, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 781291. For internatio ...

Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "U.S. Direct To Consumer Telehealth Services Market Size, Share & Trends Analysis Report By Product (Remote Monitoring, Real-time Interactions), By Delivery Mode (Web-based, Cloud-based, On-premise), And Segment Forecasts, 2024 - 2030" report has been added to ResearchAndMarkets.com's offering. The U.S. direct to consumer telehealth services market size is expected to reach USD 9.53 billion by 2030, registering a CAGR of 30.3% during the forecast period The U.S ...